Your browser doesn't support javascript.
loading
Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis.
Zhang, Lili; Zlotoff, Daniel A; Awadalla, Magid; Mahmood, Syed S; Nohria, Anju; Hassan, Malek Z O; Thuny, Franck; Zubiri, Leyre; Chen, Carol L; Sullivan, Ryan J; Alvi, Raza M; Rokicki, Adam; Murphy, Sean P; Jones-O'Connor, Maeve; Heinzerling, Lucie M; Barac, Ana; Forrestal, Brian J; Yang, Eric H; Gupta, Dipti; Kirchberger, Michael C; Shah, Sachin P; Rizvi, Muhammad A; Sahni, Gagan; Mandawat, Anant; Mahmoudi, Michael; Ganatra, Sarju; Ederhy, Stephane; Zatarain-Nicolas, Eduardo; Groarke, John D; Tocchetti, Carlo G; Lyon, Alexander R; Thavendiranathan, Paaladinesh; Cohen, Justine V; Reynolds, Kerry L; Fradley, Michael G; Neilan, Tomas G.
Afiliação
  • Zhang L; Cardiovascular Imaging Research Center, Division of Cardiology and Department of Radiology (L. Zhang, M.A., M.Z.O.H., R.M.A., A.R., T.G.N.), Massachusetts General Hospital, Boston.
  • Zlotoff DA; Cardio-Oncology Program, Division of Cardiology, Department of Medicine (L. Zhang, D.A.Z., M.A., S.P.M., M.J.-O., T.G.N.), Massachusetts General Hospital, Boston.
  • Awadalla M; Cardio-Oncology Program, Division of Cardiology, Department of Medicine (L. Zhang, D.A.Z., M.A., S.P.M., M.J.-O., T.G.N.), Massachusetts General Hospital, Boston.
  • Mahmood SS; Cardiovascular Imaging Research Center, Division of Cardiology and Department of Radiology (L. Zhang, M.A., M.Z.O.H., R.M.A., A.R., T.G.N.), Massachusetts General Hospital, Boston.
  • Nohria A; Cardio-Oncology Program, Division of Cardiology, Department of Medicine (L. Zhang, D.A.Z., M.A., S.P.M., M.J.-O., T.G.N.), Massachusetts General Hospital, Boston.
  • Hassan MZO; Cardiology Division, New York-Presbyterian Hospital, Weill Cornell Medical Center (S.S.M.).
  • Thuny F; Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA (A.N., J.D.G.).
  • Zubiri L; Cardiovascular Imaging Research Center, Division of Cardiology and Department of Radiology (L. Zhang, M.A., M.Z.O.H., R.M.A., A.R., T.G.N.), Massachusetts General Hospital, Boston.
  • Chen CL; Aix-Marseille University, Assistance Publique - Hôpitaux de Marseille, University Mediterranean Center of Cardio-Oncology, Unit of Heart Failure and Valvular Heart Diseases, Department of Cardiology, Nord Hospital, Center for Cardiovascular and Nutrition Research, France (F.T.).
  • Sullivan RJ; Mediterranean Group of Cardio-Oncology, Marseille, France (F.T.).
  • Alvi RM; Division of Oncology and Hematology, Department of Medicine (L. Zubiri, R.J.S., J.V.C., K.L.R.), Massachusetts General Hospital, Boston.
  • Rokicki A; Cardiology Service, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York (C.LC., D.G.).
  • Murphy SP; Division of Oncology and Hematology, Department of Medicine (L. Zubiri, R.J.S., J.V.C., K.L.R.), Massachusetts General Hospital, Boston.
  • Jones-O'Connor M; Cardiovascular Imaging Research Center, Division of Cardiology and Department of Radiology (L. Zhang, M.A., M.Z.O.H., R.M.A., A.R., T.G.N.), Massachusetts General Hospital, Boston.
  • Heinzerling LM; Cardiovascular Imaging Research Center, Division of Cardiology and Department of Radiology (L. Zhang, M.A., M.Z.O.H., R.M.A., A.R., T.G.N.), Massachusetts General Hospital, Boston.
  • Barac A; Cardio-Oncology Program, Division of Cardiology, Department of Medicine (L. Zhang, D.A.Z., M.A., S.P.M., M.J.-O., T.G.N.), Massachusetts General Hospital, Boston.
  • Forrestal BJ; Cardio-Oncology Program, Division of Cardiology, Department of Medicine (L. Zhang, D.A.Z., M.A., S.P.M., M.J.-O., T.G.N.), Massachusetts General Hospital, Boston.
  • Yang EH; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Germany (L.M.H., M.C.K.).
  • Gupta D; Cardio-Oncology Program, MedStar Heart and Vascular Institute, Georgetown University, Washington, DC (A.B., B.J.F.).
  • Kirchberger MC; Cardio-Oncology Program, MedStar Heart and Vascular Institute, Georgetown University, Washington, DC (A.B., B.J.F.).
  • Shah SP; UCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California at Los Angeles (E.H.Y.).
  • Rizvi MA; Cardiology Service, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York (C.LC., D.G.).
  • Sahni G; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Germany (L.M.H., M.C.K.).
  • Mandawat A; Cardiology Division, Lahey Hospital and Medical Center, Burlington, MA (S.P.S., S.G.).
  • Mahmoudi M; Division of Oncology and Hematology, Department of Medicine, Lehigh Valley Hospital, Allentown, PA (M.A.R.).
  • Ganatra S; Mount Sinai Hospital, New York (G.S.).
  • Ederhy S; Cardio-Oncology Program, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Emory University School of Medicine, Atlanta, GA (A.M.).
  • Zatarain-Nicolas E; Faculty of Medicine, University of Southampton, United Kingdom (M.M.).
  • Groarke JD; Cardiology Division, Lahey Hospital and Medical Center, Burlington, MA (S.P.S., S.G.).
  • Tocchetti CG; AP-HP, Saint-Antoine Hospital, Department of Cardiology, UNICO-GRECO Cardio-Oncology Program, Paris, France (S.E.).
  • Lyon AR; Service of Cardiology, General University Hospital Gregorio Marañón, Madrid, Spain (E.Z.-N.).
  • Thavendiranathan P; Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA (A.N., J.D.G.).
  • Cohen JV; Department of Translational Medical Sciences, Federico II University, Naples, Italy (C.G.T.).
  • Reynolds KL; Cardio-Oncology Program, Royal Brompton Hospital, and Imperial College London, United Kingdom (A.R.L.).
  • Fradley MG; Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Division of Cardiology, Toronto General Hospital, University of Toronto, Ontario, Canada (P.T.).
  • Neilan TG; Division of Oncology and Hematology, Department of Medicine (L. Zubiri, R.J.S., J.V.C., K.L.R.), Massachusetts General Hospital, Boston.
Circulation ; 141(24): 2031-2034, 2020 06 16.
Article em En | MEDLINE | ID: mdl-32539614
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Corticosteroides / Inibidores de Checkpoint Imunológico / Miocardite Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Circulation Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Corticosteroides / Inibidores de Checkpoint Imunológico / Miocardite Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Circulation Ano de publicação: 2020 Tipo de documento: Article